ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China · Delayed Price · Currency is CNY 8.80
+0.21 (2.44%)
Nov 5, 2026, 4:00 PM EST
ChemPartner PharmaTech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 423 | 411.83 | 368.33 | 347.26 | 761.66 | 160.46 |
Trading Asset Securities | 17.17 | 45.57 | 1.05 | 2.21 | - | 18.98 |
Cash & Short-Term Investments | 440.17 | 457.39 | 369.37 | 349.47 | 761.66 | 179.44 |
Cash Growth | 9.50% | 23.83% | 5.70% | -54.12% | 324.46% | -35.73% |
Accounts Receivable | 340.52 | 238.3 | 199.01 | 268.11 | 349.87 | 372.28 |
Other Receivables | 4.04 | 6.91 | 12.06 | 12.01 | 87.18 | 8.49 |
Receivables | 344.56 | 245.2 | 211.07 | 280.12 | 437.06 | 380.77 |
Inventory | 17.29 | 9.47 | 11.44 | 27.88 | 42.82 | 68.81 |
Prepaid Expenses | - | 4.77 | 0.87 | 11.03 | - | - |
Other Current Assets | 57.4 | 48.18 | 51.31 | 58.68 | 38.82 | 58.72 |
Total Current Assets | 859.42 | 765.02 | 644.07 | 727.18 | 1,280 | 687.74 |
Property, Plant & Equipment | 634.16 | 617.45 | 683.88 | 851.39 | 973.62 | 1,512 |
Long-Term Investments | 205.13 | 185.51 | 214.46 | 199.79 | 197.02 | 175.96 |
Goodwill | 0.03 | - | - | 139.26 | 858.86 | 1,207 |
Other Intangible Assets | 32.9 | 32.69 | 30.66 | 30.05 | 55.66 | 148.61 |
Long-Term Deferred Tax Assets | 54.63 | 46.75 | 39.46 | 40.45 | 10.66 | 4.89 |
Long-Term Deferred Charges | 212.25 | 238.13 | 267.09 | 324.36 | 370.23 | 385.02 |
Other Long-Term Assets | 151.03 | 147.39 | 116.18 | 121.85 | 77.49 | 96.39 |
Total Assets | 2,150 | 2,033 | 1,996 | 2,434 | 3,824 | 4,218 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 70.83 | 50.31 | 64.02 | 53.79 | 80.7 | 108.38 |
Accrued Expenses | 47.47 | 99.83 | 58.19 | 82.78 | 100.26 | 90.66 |
Short-Term Debt | 90 | 67.32 | 58.47 | 60 | 115.02 | 158.57 |
Current Portion of Long-Term Debt | 79.16 | 8.28 | 6.52 | 4.3 | 111.47 | 330.13 |
Current Portion of Leases | - | 59.63 | 73.98 | 69.63 | 67.24 | 72.83 |
Current Income Taxes Payable | 9.1 | 3.62 | 4.61 | 5.42 | 49.85 | 8.6 |
Current Unearned Revenue | 57.99 | 46.51 | 41.93 | 77.21 | 78.26 | 57.59 |
Other Current Liabilities | 77.52 | 19.95 | 38.97 | 73.63 | 129.24 | 163.91 |
Total Current Liabilities | 432.08 | 355.45 | 346.7 | 426.77 | 732.03 | 990.66 |
Long-Term Debt | 23.96 | 28.92 | 37.2 | 43.67 | 177.21 | 614.92 |
Long-Term Leases | 294.92 | 307.9 | 337.13 | 457.73 | 495.25 | 570.58 |
Long-Term Unearned Revenue | 20.7 | 23.46 | 28.36 | 27.43 | 16.41 | 20.47 |
Long-Term Deferred Tax Liabilities | 3.05 | 3.3 | 2.88 | 12.58 | 12.01 | 26.07 |
Other Long-Term Liabilities | 15.95 | 13.57 | 5.47 | 5.24 | 5.02 | 5.81 |
Total Liabilities | 790.65 | 732.59 | 757.75 | 973.44 | 1,438 | 2,229 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 504.99 | 497.96 | 497.96 | 499.78 | 499.78 | 499.78 |
Additional Paid-In Capital | 1,328 | 1,260 | 1,205 | 1,229 | 1,229 | 1,229 |
Retained Earnings | -510.83 | -497.51 | -510.92 | -284.45 | 648.27 | 269.68 |
Treasury Stock | - | - | - | -25.51 | -25.51 | -20.44 |
Comprehensive Income & Other | 7.3 | 15.99 | 21.33 | 17.64 | 9.81 | -13.76 |
Total Common Equity | 1,329 | 1,276 | 1,214 | 1,437 | 2,362 | 1,964 |
Minority Interest | 29.95 | 24.34 | 24.2 | 24.24 | 24.43 | 24.63 |
Shareholders' Equity | 1,359 | 1,300 | 1,238 | 1,461 | 2,386 | 1,989 |
Total Liabilities & Equity | 2,150 | 2,033 | 1,996 | 2,434 | 3,824 | 4,218 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 488.04 | 472.04 | 513.31 | 635.34 | 966.2 | 1,747 |
Net Cash (Debt) | -47.87 | -14.65 | -143.93 | -285.88 | -204.53 | -1,568 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.11 | -0.03 | -0.29 | -0.57 | -0.41 | -3.16 |
Filing Date Shares Outstanding | 500.47 | 497.96 | 497.96 | 497.96 | 497.96 | 498.33 |
Total Common Shares Outstanding | 500.47 | 497.96 | 497.96 | 497.96 | 497.96 | 498.33 |
Working Capital | 427.34 | 409.57 | 297.37 | 300.4 | 548.33 | -302.91 |
Book Value Per Share | 2.66 | 2.56 | 2.44 | 2.89 | 4.74 | 3.94 |
Tangible Book Value | 1,296 | 1,243 | 1,183 | 1,267 | 1,447 | 608.37 |
Tangible Book Value Per Share | 2.59 | 2.50 | 2.38 | 2.55 | 2.91 | 1.22 |
Buildings | - | 102.02 | 102.02 | 103.1 | 52.82 | 238.54 |
Machinery | - | 623.63 | 609.96 | 554.12 | 464.19 | 791.09 |
Construction In Progress | - | 4.07 | 13 | 7.96 | 75.36 | 235.74 |